Can-Fite BioPharma CANF Balance Sheet (2013-2025)

NYSE CANF
$3.42 +0.02 (+0.59%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
2.70M9.06M10.22M8.27M2.74M1.02M5.81M4.39M5.50M1.71M3.73M2.98M1.26M3.46M3.38M4.28M4.72M4.83M6.45M8.54M
Short-term Investments (Quarter)
0.06M0.08M0.07M0.36M6.51M7.50M14.51M0.18M0.04M0.01M0.01M0.02M0.01M0.00M0.02M0.01M3.06M0.00M3.01M
Cash & Current Investments (Quarter)
2.76M9.14M10.22M8.34M3.11M7.54M13.31M18.90M5.69M1.75M3.74M2.99M1.28M3.47M3.39M4.30M4.73M7.88M6.46M11.55M
Receivables - Net (Quarter)
4.38M3.57M1.06M1.02M1.75M0.81M
Receivables - Other (Quarter)
4.38M1.06M0.93M1.17M
Receivables (Quarter)
8.77M3.57M2.11M1.02M1.75M0.81M
Prepaid Assets (Quarter)
4.38M3.57M1.06M1.02M1.75M0.81M0.93M0.97M1.82M1.75M1.17M0.96M1.29M1.12M0.99M1.10M1.09M1.17M0.90M
Current Assets (Quarter)
7.14M12.70M9.40M12.62M9.55M14.47M20.07M17.67M14.59M12.56M9.16M13.38M10.91M9.06M9.91M5.83M8.98M7.62M9.44M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.04M0.03M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.04M0.04M0.03M0.03M0.03M0.03M0.01M0.01M
Long-Term Investments (Quarter)
1.57M
Long-Term Deferred Tax (Quarter)
29.53M35.89M28.63M25.14M25.61M28.06M34.09M
Other Non-Current Assets (Quarter)
Non-Current Assets (Quarter)
1.03M0.10M0.12M0.12M0.13M0.17M0.18M0.17M0.16M0.14M0.13M0.11M0.12M0.10M0.08M0.09M0.14M0.10M0.07M
Assets (Quarter)
8.17M12.80M13.33M9.52M12.74M9.68M14.64M20.25M17.85M14.75M12.71M9.28M13.49M11.03M9.17M9.99M5.92M9.12M7.72M9.51M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.16M0.44M0.78M0.56M0.29M1.00M0.81M0.95M1.12M0.82M1.47M0.90M0.96M0.81M0.65M0.43M0.89M0.62M1.15M1.16M
Payables (Quarter)
2.16M0.44M0.78M0.56M0.29M1.00M0.81M0.95M1.12M0.82M1.47M0.90M0.96M0.81M0.65M0.43M0.89M0.62M1.15M1.16M
Accumulated Expenses (Quarter)
0.61M0.47M0.33M0.73M0.31M0.30M0.91M0.91M0.46M0.46M0.78M1.10M0.60M0.75M0.94M0.43M0.98M0.51M1.11M
Other Accumulated Expenses (Quarter)
2.89M2.68M
Current Leases (Quarter)
0.04M0.04M0.04M0.04M0.04M0.04M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.03M0.03M0.04M0.05M0.06M0.06M
Current Deferred Revenue (Quarter)
0.47M0.56M0.33M1.00M0.82M0.82M3.08M0.78M2.33M2.07M1.99M1.79M1.58M
Total Current Liabilities (Quarter)
3.27M1.50M1.27M2.06M2.36M2.15M2.73M2.90M2.15M2.80M2.50M2.89M2.23M2.21M2.02M1.99M2.05M2.12M2.73M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
2.42M2.12M2.16M3.59M3.34M3.09M3.07M2.87M2.66M2.46M2.29M2.10M1.90M1.71M1.71M1.44M1.58M1.38M1.18M
Pension (Quarter)
Minority Interest (Quarter)
Operating Leases (Quarter)
0.04M0.02M0.02M0.01M0.03M0.06M0.07M0.05M0.04M0.03M0.01M0.01M0.02M0.02M0.01M0.02M0.05M0.03M0.01M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
2.46M2.14M2.18M3.60M3.37M3.15M3.14M2.92M2.70M2.48M2.31M2.10M1.93M1.72M1.73M1.46M1.63M1.42M1.19M
Total Liabilities (Quarter)
8.17M12.80M13.33M9.52M12.74M9.68M14.64M20.25M17.85M14.75M12.71M9.28M13.49M11.03M9.17M9.99M5.92M9.12M7.72M9.51M
Shareholder's Equity
Common Equity (Quarter)
2.44M9.16M6.07M7.08M3.96M9.33M14.38M12.02M9.89M7.43M4.47M8.49M6.87M5.24M6.24M2.48M5.44M4.18M5.59M
Liabilities and Shareholders Equity (Quarter)
8.17M12.80M13.33M9.52M12.74M9.68M14.64M20.25M17.85M14.75M12.71M9.28M13.49M11.03M9.17M9.99M5.92M9.12M7.72M9.51M
Treasury Shares (Quarter)
Retained Earnings (Quarter)
-110.31M-119.26M-125.47M-127.35M-130.57M-133.97M-140.67M-143.11M-145.30M-147.83M-150.85M-153.40M-155.07M-156.83M-158.48M-162.44M-166.36M-171.24M-176.19M